LL-37 2mg

LL-37 is a 37-amino acid, cationic, antimicrobial peptide derived from human cathelicidin (hCAP18), acting as a key component of the innate immune system. A 2mg peptide vial, typically used in research, provides potent broad-spectrum activity against bacteria, viruses, and fungi while aiding in immune modulation and wound healing. 

• Antimicrobial Action: Directs activity against gram-positive and gram-negative bacteria by disrupting cellular membranes.
• Immune System Modulation: Acts as an immunomodulator, regulating inflammatory responses and recruiting immune cells to infection sites.
• Wound Healing & Regeneration: Stimulates angiogenesis (new blood vessel formation) and accelerates skin barrier repair.
• Mechanism: It acts as an alpha-helical peptide that binds to negatively charged bacterial lipids (LPS) and suppresses inflammatory responses. 

• Infection Management: Investigated as an alternative to traditional antibiotics.
• Skin Health: Studies focus on treating chronic wounds, diabetic ulcers, and dermatological conditions.
• Biofilm Reduction: Used to break down bacterial biofilms

 

Disclaimer: This information is for educational purposes based on research studies and does not constitute medical advice. Consult a healthcare provider before starting any peptide therapy.